Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

Try a synonym, or sign up to request in icon from the app.

Icon Library > Proteins > Receptors and Ligands > VEGFR3

VEGFR3

VEGFR3

Use this icon in BioRender along with 1000s of others to make your next science figure in minutes

IGF-1R
GPI-anchored protein
NOD 1/2 (ligand-bound)
Laptop displaying how the icon can be used
SIGN UP FREE
[{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/elfb5m2rncxb9evxmjlv.svg#/keystone/api/icons/6051101cebe3a10026503c53/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c53/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/qiqhlw0sk7njy8va9ilz.svg#/keystone/api/icons/6051101cebe3a10026503c52/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c52/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/mgaziacihfv0ugcpcyqd.svg#/keystone/api/icons/6051101cebe3a10026503c51/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c51/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/yzgegddjqivgof8dkghz.svg#/keystone/api/icons/6051101cebe3a10026503c50/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c50/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/idtdunpxaotr1n50nhag.svg#/keystone/api/icons/6051101cebe3a10026503c4f/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4f/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/btq0nt7sng6cpu9ypdmp.svg#/keystone/api/icons/6051101cebe3a10026503c4e/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4e/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/agbgbh1ebvy5hpd6kemh.svg#/keystone/api/icons/6051101cebe3a10026503c4d/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4d/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/gjrfgzsdak8xlfjxszqw.svg#/keystone/api/icons/6051101cebe3a10026503c4c/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4c/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/efqkupb7z1rlznir97db.svg#/keystone/api/icons/6051101cebe3a10026503c4b/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4b/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/kcdgtt0voh0jdwfw0neo.svg#/keystone/api/icons/6051101cebe3a10026503c4a/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c4a/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/voqfgz3olnycvy6vrcbq.svg#/keystone/api/icons/6051101cebe3a10026503c49/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c49/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/rgxpucviphxwymtp3ow1.svg#/keystone/api/icons/6051101cebe3a10026503c48/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c48/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/wrijedpqd4num1mkxljm.svg#/keystone/api/icons/6051101cebe3a10026503c47/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c47/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/jxubxwlshiuu0z3o3m9u.svg#/keystone/api/icons/6051101cebe3a10026503c46/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c46/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/ml3nbk2mvsugbeinfyq7.svg#/keystone/api/icons/6051101cebe3a10026503c45/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c45/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/aknbu4n6gzrt0jx3fcih.svg#/keystone/api/icons/6051101cebe3a10026503c44/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c44/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/eakaliuqn3bblnykancs.svg#/keystone/api/icons/6051101cebe3a10026503c43/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c43/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/ochso4rw0jilq7tuzyzk.svg#/keystone/api/icons/6051101cebe3a10026503c42/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c42/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/g31jzgccfu1fchfwxtwk.svg#/keystone/api/icons/6051101cebe3a10026503c41/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c41/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/kxnpikpyh2zvk20xmiwt.svg#/keystone/api/icons/6051101cebe3a10026503c40/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c40/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/qsrqg8s0usm9pddqjuta.svg#/keystone/api/icons/6051101cebe3a10026503c3f/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3f/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/elyhwuxicjryapqqitnk.svg#/keystone/api/icons/6051101cebe3a10026503c3e/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3e/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/w1ridhoblxpwyrek6jrp.svg#/keystone/api/icons/6051101cebe3a10026503c3d/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3d/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/qxkpcnfi7fjoquhezaxu.svg#/keystone/api/icons/6051101cebe3a10026503c3c/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3c/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/esp8yyj3imslxaph2wpb.svg#/keystone/api/icons/6051101cebe3a10026503c3b/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3b/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/bi6jx8xyf1rywh34131j.svg#/keystone/api/icons/6051101cebe3a10026503c3a/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c3a/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/omyavrc0w8js32ycd2fv.svg#/keystone/api/icons/6051101cebe3a10026503c39/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c39/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/ibygpxzg1i2es4n0jhib.svg#/keystone/api/icons/6051101cebe3a10026503c38/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c38/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/orefd7wdba5km1eouwii.svg#/keystone/api/icons/6051101cebe3a10026503c37/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c37/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/oedvwwno9pslbmsa05ak.svg#/keystone/api/icons/6051101cebe3a10026503c36/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c36/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/epaue2nge51yus0h83y1.svg#/keystone/api/icons/6051101cebe3a10026503c35/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c35/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/psi8se3vtrn2sfbr89t4.svg#/keystone/api/icons/6051101cebe3a10026503c34/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c34/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/hnjattupe6labhmgcxmy.svg#/keystone/api/icons/6051101cebe3a10026503c33/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c33/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/mfdjbpdrbwvqzoucxskv.svg#/keystone/api/icons/6051101cebe3a10026503c32/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c32/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/redofqv94e5xis5vcbku.svg#/keystone/api/icons/6051101cebe3a10026503c31/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c31/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/kvgjn8qs9nfisndlfzai.svg#/keystone/api/icons/6051101cebe3a10026503c30/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c30/vegfr3-2.png"},{"image":"https://res.cloudinary.com/dlcjuc3ej/image/upload/v1615925269/hgdbksltjjqvbpaplh7e.svg#/keystone/api/icons/6051101cebe3a10026503c2f/vegfr3-2.svg","waterMarkImage":"https://icons.biorender.com/w550xh620/6051101cebe3a10026503c2f/vegfr3-2.png"}]
Keywords
VEGF receptor,VEGFR3,vascular endothelial growth factor 3,vascular permeability factor 3,VPF3,VEGF,membrane bound,mbVEGFR,soluble,sVEGFR,monomer,growth factor,platelet-derived growth factor,cystine-knot,vasculogenesis,vascular endothelium,mitogenesis,cell migration,microvascular permeability,tyrosine kinase,transphosphorylation,immunoglobulin-like domains,VEGFR3

Other Icons in  Receptors and Ligands

IGF-1R
IGF-1R
GPI-anchored protein
GPI-anchored protein
NOD 1/2 (ligand-bound)
NOD 1/2 (ligand-bound)
TLR (bound to ssRNA)
TLR (bound to ssRNA)
TLR (bound to dsDNA)
TLR (bound to dsDNA)
BCR (labeled)
BCR (labeled)
BCR (antigen cross-linked)
BCR (antigen cross-linked)
CD21 (editable)
CD21 (editable)
CD45 (editable)
CD45 (editable)
CD22 and CD45 (editable)
CD22 and CD45 (editable)
CD20
CD20
C1 complex (with C1s and C1r)
C1 complex (with C1s and C1r)
Arrow, back, chevron icon
BACK TO LIBRARY HOME
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web-based software that helps you create scientific figures in minutes. Our program has a library of more than 30,000 life science icons, as well as drag-and-drop functionality to help you make professional figures quickly.
How can I use this icon?
You can use this icon and thousands more by signing up for a BioRender account at https://app.biorender.com
I want a variation of this icon. How do I know if it's available?
You can browse our library by typing in the search bar above or sign up for BioRender and search in the app. Can't find an icon? Premium users can request custom icons and we'll make them in as little as 48 hours.
Where can I use figures I make with this icon?
Figures made in BioRender can always be used for educational use. If you'd like to use a figure for a publication, you must be registered for a premium plan. You can find more details on our pricing page
I have other questions. How do I contact support?
You can contact us anytime at support@biorender.com. We aim to get back to all requests within 24 hours.
Chat Button
Chat
BioRender uses cookies to improve our user experience. By continuing to our site, you agree to our use of cookies outlined in our Privacy Policy.
Agree